Knowing that Nasrat is an attorney as well, what do you speculate his plan of actions are to get the FDA to take another look at our BE data compared to all the other Oxicodone products currently in the market?
If they all have TMax issues/concerns, then why could we not just simply use the same labeling / instructions as well?
Thank you very much again for your in depth knowledge and helping us all understand things better!
Market Data 
Markets 
AI
